---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018806"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T03:03:09.290701+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QHSLab Q1 revenue up 39% to $488K; posts positive operating income of $13.6K vs loss of $120.8K year ago

## Summary
- Q1 2024 revenue $488,587 (+38.6% YoY); Integrated Service Program revenue surged 268% to $127,004.
- Gross margin improved to 58.6% from 53.1%; gross profit $286,158.
- Operating expenses decreased 11.5% to $272,554; net operating income turned positive to $13,604 from a loss of $120,758.
- Allergy Diagnostic Kit sales rose 21% to $237,066; no EPS or net income figures disclosed.

## SEC filing metadata
- accession: 0001493152-24-018806
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315224018806/0001493152-24-018806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315224018806/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018806
- JSON: https://secwatch.observer/filing/0001493152-24-018806.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.